Cengild debuts on ACE Market at 50% premium of 49.5 sen a share


L to R: Emeritus Professor Datuk Goh Khean Lee, Executive Director, Cengild Medical Bhd; Lee Jim Leng, Group Managing Director/CEO, Hong Leong Investment Bank Bhd, Datuk Tan Huck Joo, Executive Chairman, Cengild Medical; Chong Su-Lin, Independent Non-Executive Director, Cengild Medical; Lily Yap, CEO, Cengild Medical; Mohamed Akhtar Mohamed Ditali Qureshi, Executive Director, Cengild Medical; and Azrina Abu Bakar, Independent Non-Executive Director, Cengild Medical

KUALA LUMPUR: Cengild Medical Bhd made its debut on the ACE Market of Bursa Malaysia today at 49.5 sen a share, a 50% premium to its issue price of 33 sen.

"Cengild has travelled through a remarkable journey since October 2017 and this IPO has provided us with the platform to realize our ambitions and accelerate our expansion plans.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

DNB announces new board members comprising representatives from all five MNOs
Axiata, Sinar Mas move closer to US$3.5bil telco merger
Agricore gets Bursa nod to list on ACE Market
South Korea Q1 GDP growth smashes estimates, but outlook's uncertain
Ringgit soft as US$ remains elevated
Product innovation drives sales of local plastic packaging
Bursa's rally continues ahead of economic releases
Trading ideas: MyEG, Axis REIT, Mah Sing, Capital A, Hibiscus, Chin Hin, Carlsberg, I-Bhd
Kering says profit likely to tumble
Businesses concerned about rising forex woes

Others Also Read